Mohamed Al Rawahi

Appropriate Antiviral Therapy can Prevent Hepatitis B Reactivation and Progression in Chronic Myeloid Leukemia on Therapy with Tyrosine Kinase Inhibitors

Antiviral Therapy and Hepatitis B Reactivation Outcomes in Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Retrospective Cohort Study

Objectives: Viral Hepatitis reactivation can occur in patients receiving tyrosine kinase inhibitors (TKIs), with potentially fatal complications. We aimed to assess hepatitis reactivation in patients with chronic myeloid leukemia (CML) treated with TKIs. Methods: We retrospectively reviewed the clinical and laboratory …

Physician Burnout: Systemic Challenges and Individual Resilience

Physician burnout is a multifaceted syndrome characterized by emotional exhaustion, depersonalization and a diminished sense of personal accomplishment. It affects physicians at various stages of their medical training more prevalently than their peers in the general population. This article aims to explore the systemi …

Neurofibromatosis with Bilateral Renal Artery Stenosis and End Stage Renal Disease: Case Report

Neurofibromatosis type 1 (NF-1) is an autosomal dominant, hereditary, neurocutaneous syndrome that may, primarily or secondarily, affect different organs or systems of the body including the cardiovascular system. The most common vascular abnormality in patients with NF-1 is renal artery stenosis. Here we report the ca …

Artificial Intelligence in Medicine: A Double-edged Sword or a Pandora’s Box?

Artificial intelligence (AI), defined as the simulation of human intelligence processes by computer systems, has invaded many industries, including medicine. AI holds significant promise in healthcare, with the potential to enhance diagnostics, treatment, and patient care. However, like any groundbreaking technology, i …